drugset / Trial / NCT06858423

Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients

NCT06858423

Phase 4 Completed 360 enrolled Benha University
RandomizedParallel-groupOpen-labelTreatment

Summary

Budesonide is a medication of the corticosteroid type. Available as an inhaler, nebulization solution, The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease is used for allergic rhinitis and nasal polyps fluticasone propionate

Timeline

Start
2023-08-15
Primary completion
2024-03-31
Completion
2024-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Intranasal
Subject Fluticasone propionate Other / unclassified Intranasal

Indications